CDKN2A and head and neck squamous cell carcinoma: Mazurek et al. and Perdomo et al. have shown that somatic alterations of either KRAS and EGFR or TP53, NOTCH1, CDKN2A, CAP8, and PTEN could be used for the diagnostic purpose by liquid biopsy in HNSCC (59, 62).